Expiration date: 07/2025

Latin name: Gleacer 

The active ingredient: Choline alphosceratus (Choline alfoscerate) 

ATX

N07AX02 of Choline alphosceratus

Pharmacological group: Nootropics

Description of the active substance. Given the scientific information is generalizing and cannot be used for decision about the possibility of using a specific drug.

The testimony of the drug

Traumatic brain injury (the acute period) with a predominantly stem the level of the lesion, chronic cerebrovascular insufficiency (discirkulatornaya encephalopathy), dementia (Alzheimer's type, senile, mixed forms), ischemic stroke (recovery period), Huntington's chorea, functional disorders of the Central nervous system, impaired memory, confusion, disorientation, decreased motivation, initiative and concentration, senile psevdomelanjolia.

Contraindications

Hypersensitivity, pregnancy, breast-feeding.

Application of pregnancy and breastfeeding

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

Side effects

Nausea, allergic reactions.

Special instructions

With nausea it is recommended to reduce the dose.

Storage conditions of the drug Gleacer

In a dry, protected from light place, at temperature not above 25 °C.

Keep out of reach of children.

The shelf life of the drug Gleacer

5 years.